Fred Hutchinson Cancer Center
United States
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome
Colorectal cancer (CRC) affects ~145,000 people/year in the US and is the 3rd most common cause of cancer related deaths. CRC arises from early lesions that are pre-cancerous; these early lesions are colon adenomas and serrated sessile lesions (SSL). Colon adenomas account for 80-85% of the CRC precancerous lesions and progress to CRC via an early adenomaàadvanced adenomaàCRC sequence. In light of the well characterized clinical natural history of adenomas, we plan to study them as early lesions and to determine the mechanisms involved in the formation and progression of early precancerous lesions. Notably, only a few early adenomas will progress to advanced adenomas (AA) and even fewer will progress to CRC. Our group and others have shown that mutations alone are not sufficient to cause adenoma initiation and/or progression in the majority of cases. There are likely multiple adenoma nonautonomous mechanisms that cooperate with the DNA alterations in the adenomas to cause progression, and these mechanisms are likely operative in discrete subsets of affected individuals. We and others have observed alterations, such as tissue senescence, high cancer driver gene mutation loads, aberrant DNA methylation patterns, and dysbiotic gut microbiomes, in the normal colon of people with advanced adenomas and CRC patients. We have termed normal colons with these features “primed colons” and propose that these features are plausible mechanisms that affect adenoma initiation and progression. Based on these observations and our prior studies, we hypothesize that early lesion progression requires a suite of hallmark behaviors and that these behaviors are induced by adenoma autonomous factors (e.g. cancer driver gene mutations) and adenoma nonautonomous factors from the “primed colon” or adenoma microenvironment. Our proposed studies will integrate basic and translational cancer research Projects to iteratively examine the direct causal relationships and interactions of adenomas, the colon “primed” microenvironment, and hostsystemic factors as “co-organizers” of adenoma initiation and/or progression. The Specific Aims are: Aim 1) To determine the adenoma cell autonomous molecular factors that distinguish nonadvanced adenomas from advanced adenomas and that regulate nonadvanced adenoma progression. (Projects 1 and 2) Aim 2) To determine the adenoma nonautonomous factors from the “primed” colon and from the adenoma microenvironment that associate with advanced human colon adenomas and regulate adenoma progression. These factors will include the following “primed” colon states: 1. senescence state; 2. cancer driver gene mutation burden; 3. gut microbiome state; 4. colon methylome, and 5. colon immune activity state. (Projects 1-3) Aim 3)To determine how adenoma autonomous and nonautonomous factors from the adenoma microenvironment and the “primed” colon cooperate to drive adenoma formation and progression.(Projcts 1-3)
Publications
- Koester ST, Li N, Dey N. RET is a sex-biased regulator of intestinal tumorigenesis. Frontiers in gastroenterology (Lausanne, Switzerland). 2023;2. Epub 2024 Jan 16. PMID: 39148929
- Kopyeva I, Bretherton RC, Ayers JL, Yu M, Grady WM, DeForest CA. Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels. ACS biomaterials science & engineering. 2025 May 12;11(5):2810-2823. Epub 2025 Apr 30. PMID: 40304602
- Yu M, Carter KT, Baker KK, Redman MW, Wang T, Vickers K, Li CI, Cohen SA, Krane M, Ose J, Gigic B, Figueiredo JC, Toriola AT, Siegel EM, Shibata D, Schneider M, Ulrich CM, Dzubinski LA, Schoen RE, Grady WM. Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2023 Sep 1;32(9):1146-1152. PMID: 37294695
- Minot SS, Li N, Srinivasan H, Ayers JL, Yu M, Koester ST, Stangis MM, Dominitz JA, Halberg RB, Grady WM, Dey N. Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change. Scientific reports. 2024 Oct 9;14(1):23646. PMID: 39384807
- Matas J, Kohrn B, Fredrickson J, Carter K, Yu M, Wang T, Gui X, Soussi T, Moreno V, Grady WM, Peinado MA, Risques RA. Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon. Cancer research. 2022 Apr 15;82(8):1492-1502. PMID: 35425963
- Stangis MM, Chen Z, Min J, Glass SE, Jackson JO, Radyk MD, Hoi XP, Brennen WN, Yu M, Dinh HQ, Coffey RJ, Shrubsole MJ, Chan KS, Grady WM, Yegnasubramanian S, Lyssiotis CA, Maitra A, Halberg RB, Dey N, Lau KS. The Hallmarks of Precancer. Cancer discovery. 2024 Apr 4;14(4):683-689. PMID: 38571435
- Hattangady NG, Carter K, Maroni-Rana B, Wang T, Ayers JL, Yu M, Grady WM. Mapping the core senescence phenotype of primary human colon fibroblasts. Aging. 2024 Feb 21;16(4):3068-3087. Epub 2024 Feb 21. PMID: 38385965
- Dey N. Picking up microbial clues in early-onset colorectal cancer. Gut. 2023 Jun;72(6):1029-1030. Epub 2022 Nov 2. PMID: 36323504
- Gupta A, Morella N, Sutormin D, Li N, Gaisser K, Robertson A, Ispolatov Y, Seelig G, Dey N, Kuchina A. Combinatorial phenotypic landscape enables bacterial resistance to phage infection. bioRxiv : the preprint server for biology. 2025 Jan 14. PMID: 39868116
- Hanna M, Dey N, Grady WM. Emerging Tests for Noninvasive Colorectal Cancer Screening. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2023 Mar;21(3):604-616. Epub 2022 Dec 17. PMID: 36539002
- Orouskhani M, Rauniyar S, Morella N, Lachance D, Minot SS, Dey N. Deep learning imaging analysis to identify bacterial metabolic states associated with carcinogen production. Discover imaging. 2025;2(1):2. Epub 2025 Mar 10. PMID: 40098681
- Pooler BD, Kim DH, Matkowskyj KA, Newton MA, Halberg RB, Grady WM, Hassan C, Pickhardt PJ. Natural History of Colorectal Polyps Undergoing Longitudinal in Vivo CT Colonography Surveillance. Radiology. 2024 Jan;310(1):e232078. PMID: 38289210
- Ganesh N, Grady WM, Kaz AM. Epigenetic Alterations in Colitis-Associated Colorectal Cancer. Epigenomes. 2026 Jan 16;10. (1). PMID: 41562706